Skip to main content
. 2021 Aug 27;8:722866. doi: 10.3389/fnut.2021.722866

Table 3.

Study design, characteristics, and summary of outcomes.

Author, country, year Design of randomized controlled trial Participants Intervention, number (male/female), daily dose Control, number (male/female), daily dose Duration Effect Risk of bias
McGeoch et al. (29) United Kingdom Crossover Type 2 diabetes, 40–75 years Oat-based product, 27 (18/9), 60–100 g Standard diet, 27 (18/9), NA 8 weeks ↔ CRP, IL-18, Adiponectin Some concerns
Koenig et al. (27) United States Parallel Young female aged 18–30 Avenanthramides in oat cookies, 8 (0/8), 9.2 mg Avenanthramides; oat flour cookies, 8 (0/8), 0.4 mg 8 weeks ↓ NRB, IL-6, TNF-α, CRP ↔ IL-1b Low risk
Koenig et al. (16) United States Parallel Female aged 50–80 Avenanthramides in oat cookies, 8 (0/8), 9.2 mg Avenanthramides; oat flour cookies, 8 (0/8), 0.4 mg 8 weeks ↓ IL-1B, NRB, CRP ↔ IL-6, TNF-α Low risk
Zhang T et al. (34) United States Parallel Healthy subjects, 23.0 ± 1.2 years Avenanthramides in oat cookies, 12 (NA), 20.6 mg Avenanthramides; oat flour cookies, 12 (NA), 0 mg 8 weeks ↓ IL-1Ra, sVCAM-1, G-CSF, NRB ↔ IL-6, MCP-1, CK High risk
Nieman et al. (17) United States Parallel Healthy male subjects Oat β-glucan in beverage, 19 (19/0), 5.6 g/600 mL Cornstarch in beverage, 17 (17/0), 600 mL 14 days ↔ IL-6, IL-10, IL-8, IL-1Ra Some concerns
Tighe P et al. (33) United Kingdom Parallel Middle aged (40–65 y), healthy subjects Oat cereals, 70 (36/34), 60–80 g Whole-grain cereals, 73 (38/35), 90–120 g 12 weeks ↔ hs-CRP, IL-6 Some concerns
Fazilaty et al. (26) Iran Parallel Multiple trauma, ≥18 years Oat β-glucan, 20 (18/2), 3 g Maltodextrin, 20 (18/2), 3 g 21 days ↑ IL-12 ↔ hs-CRP Some concerns
Ma et al. (28) China Parallel Type 2 diabetes, 50–60 years Organic naked oat with whole germ porridge, 65 (27/38), 50 g Diet group, 61 (28/33), balance nutritional composition without oat 30 days ↔ hs-CRP Some concerns
Organic naked oat with whole germ porridge, 65 (27/38), 100 g Diet group, 61 (28/33), balanced nutritional composition without oat 30 days ↓ hs-CRP
Ganda Mall et al. (31) Sweden Parallel Healthy subjects, ≥65 years Oat β-glucan powder, 15 (9/6), 12 g Maltodextrin powder, 17 (9/8), 12 g 6 weeks ↔ IFN-γ, IL-10, CRP, IL-1b, IL-2, IL-6, IL-8, TNF-α, IL-12p70 Some concerns
Arabinoxylan powder, 17 (9/8), 12 g 6 weeks ↔ IFN-γ, IL-10, CRP, IL-1b, IL-2, IL-6, IL-8, TNF-α, IL-12p70
Sirtori et al. (37) Italy Parallel Moderate hypercholesterolemia Oat fiber containing 25-28% β-glucan with casein bar, 22 (NA), 10.5 g Cellulose with casein bar, 25 (10/15), 10 g 4 weeks ↔ Adiponectin, sICAM-1, IL-6, hs-CRP High risk
Oat fiber containing 25-28% β-glucan with casein bar, 23 (NA), 10.5 g Cellulose with casein bar, 25 (11/14), 10 g 4 weeks ↔ Adiponectin, sICAM-1, IL-6, hs-CRP
Connolly et al. (35) United Kingdom Crossover Healthy subjects, 19–60 years Whole grain oat granola, 30 (11/19), 45 g Non-whole grain cereal, 30 (11/19), 45 g 6 weeks ↔ CRP, TNF-α, IL-6, Calprotectin, Ig A Low risk
Xia et al. (39) China Parallel Healthy male, 19.7 ± 1.1 years Oat protein beverage, 8 (8/0), 25 g Maltodextrin beverage, 8 (8/0), 25 g 19 days ↓ CRP, IL-6 Low risk
Thompson et al. (38) United States Parallel Healthy male, 18–30 years β-Glucan (oat bran) powder, 9 (9/0), 3 g Muffin mix powder, 11 (11/0), 3 g 4 weeks ↓ 24 h soreness score High risk
Theuwissen et al. (18) Netherlands Crossover Mild hypercholesterolemia, 52 ± 11 years Oat β-glucan in muesli, 30 (NA), 4.8 g Wheat fiber in muesli, 30 (NA), 4.8 g 4 weeks ↔ TNF-α, IL-6, IL-8, hs-CRP High risk
Pavadhgul P et al. (36) Thailand Crossover Hypercholesterolemia, 30–60 years Oat porridge, 24 (NA), 70 g Rice porridge, 24 (NA), 70 g 4 weeks ↓ hs-CRP, IL-6, IL-8, TNF-α, MCP-1 High risk
Zhang et al. (44) United Kingdom Crossover Type 2 diabetes, 40–75 years Oat-enriched diet (commercial product), 22 (NA), 131 g Non-oat product (daily meal), 22 (NA), NA 8 weeks ↔ P-selectin, CRP, IL-18 High risk
Sawicki CM et al. (41) United States Crossover Overweight or mildly obese, metabolically at-risk, 40–70 years Whole oat flour muffins, 13 (8/5), 48 g Refined wheat flour muffins, 13 (8/5), 48 g 1 day ↔ hs-CRP, IL-6, IL-8, TNF-α Some concerns
Biörklund et al. (40) Sweden Parallel Healthy, but with mildly elevated serum cholesterol levels, 35–72 years Oat β-glucan soup, 22 (NA), 4 g per 400 g soup Placebo soup, 21 (NA), 0 g per 400 g soup 5 weeks ↔ hs-CRP Some concerns
Sturtzel et al. (42) Austria Parallel Frail patients (57–98 years), who are geriatric hospital residents with multiple chronic diseases and require assistance for their daily life activities Oat flakes (oat-bran product) blended into common daily meals, 15 (NA), 5.2 g Ward's habitual diet, 15 (NA), NA 12 weeks ↓ CRP Some concerns
Queenan et al. (32) United States Parallel Hypercholesterolemia, 22–65 years Oat β-glucan powder in beverage, 35 (22/13), 6 g Dextrose powder in beverage, 40 (28/12), 6 g 6 weeks ↔ CRP Some concerns
Cugnet-Anceau et al. (30) France Parallel Type 2 diabetes, 30–75 years Soup containing oat β-glucan, 29 (NA), 3.5 g in 400 g Soup without oat β-glucan, 24 (NA), 0 g in 400 g 11 weeks ↔ CRP Some concerns
Maki et al. (45) United States Parallel Overweight and obese adults Whole-grain oat cereal, 77 (NA), 40 g (providing 3 g β-glucan) Low-fiber breakfast/snack foods, 67 (NA), ~500 kcal 12 weeks ↔ hs-CRP Some concerns
Wolever et al. (43) Canada Parallel Healthy subjects, 20–65 years High-molecular-weight oat β-glucan-containing cereals, 81 (43/43), 3 g Wheat bran-containing cereals, 87 (36/51), NA 4 weeks ↔ CRP Some concerns
Medium-molecular-weight oat β-glucan-containing cereals, 67 (33/34), 4 g 4 weeks ↔ CRP
Medium-molecular-weight oat β-glucan-containing cereals, 64 (27/37), 3 g 4 weeks ↔ CRP
Low-molecular-weight oat β-glucan-containing cereals, 63 (22/41), 4 g 4 weeks ↔ CRP

NA, not available; ↔, no significant change; ↓, significant decrease (p <0.05); ↑, significant increase (p < 0.05).